Verrica Pharmaceuticals Inc.(VRCA)
Pharmaceuticals
Specialty Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-11-25 | Zawitz David Chief Operating Officer | Purchase | +12,500 | +147.06%21,000 | $3.39 | $42,425 | View SEC filing | |
| 2025-11-25 | Rieger Jayson CEO and President | Purchase | +117,888 | +180.23%183,298 | $3.39 | $400,114 | View SEC filing | |
| 2025-11-25 | Rosenberg Noah L. CMO | Purchase | +2,946 | +100.00%2,946 | $3.39 | $10,000 | View SEC filing | |
| 2025-11-25 | Kirby John J. Interim CFO | Purchase | +4,420 | +97.31%8,962 | $3.39 | $15,001 | View SEC filing | |
| 2025-11-25 | Manning Paul B Director, 10% Owner | Purchase | +5,157,677 | +185.89%7,932,218 | $3.39 | $17,505,157 | View SEC filing | |
| 2025-03-18 | Hayes Christopher G. CHIEF LEGAL OFFICER | Sale | -4,315 | -2.39%176,458 | $0.65 | $2,805 | View SEC filing | |
| 2024-11-26 | Rieger Jayson CEO and President | Purchase | +561,796 | +171.23%889,881 | N/A | N/A | View SEC filing | |
| 2024-11-26 | Stalfort John A III Director | Purchase | +2,247,189 | +320.93%2,947,394 | N/A | N/A | View SEC filing | |
| 2024-11-26 | Manning Paul B Director, 10% Owner | Purchase | +45,842,696 | +294.06%61,432,177 | N/A | N/A | View SEC filing | |
| 2024-08-28 | Hayes Christopher G. CHIEF LEGAL OFFICER | Sale | -35,713 | -25.24%105,773 | $2.61 | $93,091 | View SEC filing | |
| 2024-08-28 | Goldenberg Gary Chief Medical Officer | Sale | -13,489 | -12.52%94,261 | $2.61 | $35,161 | View SEC filing | |
| 2024-08-28 | Bonaccorso Joe CHIEF COMMERCIAL OFFICER | Sale | -33,702 | -31.55%73,114 | $2.61 | $87,849 | View SEC filing | |
| 2024-08-28 | Kohler Terry CHIEF FINANCIAL OFFICER | Sale | -29,719 | -39.94%44,697 | $2.61 | $77,473 | View SEC filing | |
| 2024-08-28 | White Ted PRESIDENT AND CEO | Sale | -34,000 | -13.60%215,967 | $2.61 | $88,636 | View SEC filing | |
| 2024-07-23 | White Ted PRESIDENT AND CEO | Sale | -32,623 | -11.54%249,967 | $7.06 | $230,306 | View SEC filing | |
| 2024-07-23 | Bonaccorso Joe CHIEF COMMERCIAL OFFICER | Sale | -25,576 | -19.32%106,816 | $7.06 | $180,557 | View SEC filing | |
| 2024-07-23 | Goldenberg Gary Chief Medical Officer | Sale | -18,507 | -14.66%107,750 | $7.06 | $130,653 | View SEC filing | |
| 2024-07-23 | Hayes Christopher G. CHIEF LEGAL OFFICER | Sale | -21,740 | -13.32%141,486 | $7.06 | $153,477 | View SEC filing | |
| 2023-12-29 | EDELMAN JOSEPH 10% Owner | Purchase | +321,616 | +4.75%7,099,182 | $7.17 | $2,305,132 | View SEC filing | |
| 2023-12-26 | EDELMAN JOSEPH 10% Owner | Purchase | +504,652 | +8.04%6,777,566 | $6.45 | $3,256,191 | View SEC filing | |
| 2023-12-19 | EDELMAN JOSEPH 10% Owner | Purchase | +1,233,931 | +24.49%6,272,914 | $5.63 | $6,941,716 | View SEC filing | |
| 2023-11-16 | Bonaccorso Joe Chief Commercial Officer | Sale | -32,846 | -26.23%92,392 | $2.94 | $96,689 | View SEC filing | |
| 2023-11-16 | Goldenberg Gary Chief Medical Officer | Sale | -8,853 | -9.31%86,257 | $2.94 | $26,061 | View SEC filing | |
| 2023-11-16 | Kohler Terry Chief Financial Officer | Sale | -28,084 | -44.93%34,416 | $2.94 | $82,671 | View SEC filing | |
| 2023-11-16 | White Ted President and CEO | Sale | -33,699 | -16.54%170,090 | $2.94 | $99,200 | View SEC filing |
1-25 of 122